Mei‐Wei Lin

545 total citations
16 papers, 411 citations indexed

About

Mei‐Wei Lin is a scholar working on Molecular Biology, Genetics and Biomedical Engineering. According to data from OpenAlex, Mei‐Wei Lin has authored 16 papers receiving a total of 411 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 5 papers in Genetics and 3 papers in Biomedical Engineering. Recurrent topics in Mei‐Wei Lin's work include CRISPR and Genetic Engineering (10 papers), Viral Infectious Diseases and Gene Expression in Insects (7 papers) and Virus-based gene therapy research (2 papers). Mei‐Wei Lin is often cited by papers focused on CRISPR and Genetic Engineering (10 papers), Viral Infectious Diseases and Gene Expression in Insects (7 papers) and Virus-based gene therapy research (2 papers). Mei‐Wei Lin collaborates with scholars based in Taiwan, Vietnam and United States. Mei‐Wei Lin's co-authors include Yu‐Chen Hu, Mu‐Nung Hsu, Chih‐Che Shen, Vu Anh Truong, Yu‐Han Chang, Jih Ru Hwu, Shiaw‐Min Hwang, Chin‐Yu Lin, Li‐Yu Sung and Chi‐Shiun Chiang and has published in prestigious journals such as Nucleic Acids Research, ACS Nano and Biomaterials.

In The Last Decade

Mei‐Wei Lin

15 papers receiving 409 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mei‐Wei Lin Taiwan	11	294	85	75	32	29	16	411
Krzysztof Dariusz Pluta Poland	8	281 1.0×	67 0.8×	97 1.3×	33 1.0×	20 0.7×	19	425
Elaheh Sadat Hosseini Iran	11	308 1.0×	61 0.7×	109 1.5×	55 1.7×	44 1.5×	17	447
Mohamed Mashal Spain	13	392 1.3×	58 0.7×	105 1.4×	25 0.8×	87 3.0×	21	564
Wen‐Hsin Lo Taiwan	11	257 0.9×	108 1.3×	129 1.7×	51 1.6×	39 1.3×	13	432
Xuehui Rui China	4	391 1.3×	44 0.5×	93 1.2×	19 0.6×	60 2.1×	10	479
Yongsheng Zhang China	13	247 0.8×	56 0.7×	79 1.1×	18 0.6×	40 1.4×	36	455
Jason L. Andresen United States	9	357 1.2×	83 1.0×	58 0.8×	22 0.7×	83 2.9×	10	522
Chenfei Wang China	7	188 0.6×	46 0.5×	63 0.8×	20 0.6×	32 1.1×	17	279
Hanieh Moradian Germany	8	159 0.5×	80 0.9×	36 0.5×	23 0.7×	76 2.6×	14	310

Countries citing papers authored by Mei‐Wei Lin

Since Specialization

Citations

This map shows the geographic impact of Mei‐Wei Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mei‐Wei Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mei‐Wei Lin more than expected).

Fields of papers citing papers by Mei‐Wei Lin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mei‐Wei Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mei‐Wei Lin. The network helps show where Mei‐Wei Lin may publish in the future.

Co-authorship network of co-authors of Mei‐Wei Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Mei‐Wei Lin. A scholar is included among the top collaborators of Mei‐Wei Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mei‐Wei Lin. Mei‐Wei Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Li, Chung‐Pin, Mei‐Wei Lin, Min‐Yuan Chou, et al.. (2024). Robust and Sustained STING Pathway Activation via Hydrogel-Based In Situ Vaccination for Cancer Immunotherapy. ACS Nano. 18(43). 29439–29456. 20 indexed citations

Lin, Yen-Ju, et al.. (2023). A CMOS/Microfluidics Point-of-Care SoC employing Square-Wave Voltcoulometry for Biosensing with Aptamers and CRISPR-Cas12a Enzymes. 1–2. 2 indexed citations

Lin, Mei‐Wei, et al.. (2021). Polyplex nanomicelle delivery of self-amplifying RNA vaccine. Journal of Controlled Release. 338. 694–704. 11 indexed citations

Shen, Chih‐Che, Mu‐Nung Hsu, Mei‐Wei Lin, et al.. (2021). Synthetic biology approach to developing all-in-one baculovirus vector using mammalian introns and miRNA binding sites. Journal of the Taiwan Institute of Chemical Engineers. 131. 104175–104175. 3 indexed citations

Lin, Mei‐Wei, Chih‐Che Shen, Yen-Ju Lin, et al.. (2021). Enhancing the yield and activity of defucosylated antibody produced by CHO-K1 cells using Cas13d-mediated multiplex gene targeting. Journal of the Taiwan Institute of Chemical Engineers. 121. 38–47. 7 indexed citations

Hsu, Mu‐Nung, Yu‐Han Chang, Vu Anh Truong, et al.. (2020). CRISPR interference-mediated noggin knockdown promotes BMP2-induced osteogenesis and calvarial bone healing. Biomaterials. 252. 120094–120094. 45 indexed citations

Shen, Chih‐Che, et al.. (2020). CRISPR-Cas13d for Gene Knockdown and Engineering of CHO Cells. ACS Synthetic Biology. 9(10). 2808–2818. 19 indexed citations

Hsu, Mu‐Nung, Po‐Liang Lai, Vu Anh Truong, et al.. (2019). Coactivation of Endogenous Wnt10b and Foxc2 by CRISPR Activation Enhances BMSC Osteogenesis and Promotes Calvarial Bone Regeneration. Molecular Therapy. 28(2). 441–451. 53 indexed citations

Truong, Vu Anh, Mu‐Nung Hsu, Mei‐Wei Lin, et al.. (2019). CRISPRai for simultaneous gene activation and inhibition to promote stem cell chondrogenesis and calvarial bone regeneration. Nucleic Acids Research. 47(13). e74–e74. 55 indexed citations

10.

Sung, Li‐Yu, Mengying Wu, Mei‐Wei Lin, et al.. (2019). Combining orthogonal CRISPR and CRISPRi systems for genome engineering and metabolic pathway modulation in Escherichia coli. Biotechnology and Bioengineering. 116(5). 1066–1079. 28 indexed citations

11.

Lin, Mei‐Wei, Mu‐Nung Hsu, Yu‐Chan Chao, et al.. (2018). Graphene oxide sensitizes cancer cells to chemotherapeutics by inducing early autophagy events, promoting nuclear trafficking and necrosis. Theranostics. 8(9). 2477–2487. 55 indexed citations

12.

Shen, Chih‐Che, et al.. (2018). Synthetic switch to minimize CRISPR off-target effects by self-restricting Cas9 transcription and translation. Nucleic Acids Research. 47(3). e13–e13. 59 indexed citations

13.

Lin, Mei‐Wei, Chih‐Che Shen, Mu‐Nung Hsu, et al.. (2018). Synthetic switch-based baculovirus for transgene expression control and selective killing of hepatocellular carcinoma cells. Nucleic Acids Research. 46(15). e93–e93. 20 indexed citations

14.

Shen, Chih‐Che, Li‐Yu Sung, Shih-Yeh Lin, Mei‐Wei Lin, & Yu‐Chen Hu. (2017). Enhancing Protein Production Yield from Chinese Hamster Ovary Cells by CRISPR Interference. ACS Synthetic Biology. 6(8). 1509–1519. 26 indexed citations

15.

Kuo, Zong‐Keng, Mei‐Wei Lin, Siyuan Wu, et al.. (2016). Antiangiogenic and antihepatocellular carcinoma activities of the Juniperus chinensis extract. BMC Complementary and Alternative Medicine. 16(1). 277–277. 8 indexed citations

16.

Lin, Mei‐Wei, et al.. (2001). Role of Tole in Vibrio vulnificus Virulence in Mice. 59–62.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact